Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoelzer

Showing results (411-420 of 415) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 415 results.
Leukemia|December 6, 2012
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemiaH Pfeifer, B Wassmann, W Bethge, et al.
Blood Cancer Journal|September 24, 2016
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemiaN Gökbuget, M Kelsh, V Chia, et al.
Blood|January 15, 1996
Improved outcome in adult B-cell acute lymphoblastic leukemiaD Hoelzer, W D Ludwig, E Thiel, et al.
Leukemia|December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008M Brüggemann, A Schrauder, T Raff, et al.
Leukemia|March 27, 2004
The German competence network 'Acute and chronic leukemias'R Hehlmann, U Berger, C Aul, et al.
Pageof 42

Showing results (411-420 of 415) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 415 results.
Leukemia|December 6, 2012
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemiaH Pfeifer, B Wassmann, W Bethge, et al.
Blood Cancer Journal|September 24, 2016
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemiaN Gökbuget, M Kelsh, V Chia, et al.
Blood|January 15, 1996
Improved outcome in adult B-cell acute lymphoblastic leukemiaD Hoelzer, W D Ludwig, E Thiel, et al.
Leukemia|December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008M Brüggemann, A Schrauder, T Raff, et al.
Leukemia|March 27, 2004
The German competence network 'Acute and chronic leukemias'R Hehlmann, U Berger, C Aul, et al.
Pageof 42